These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
437 related articles for article (PubMed ID: 28676490)
1. TGF-β promotes PI3K-AKT signaling and prostate cancer cell migration through the TRAF6-mediated ubiquitylation of p85α. Hamidi A; Song J; Thakur N; Itoh S; Marcusson A; Bergh A; Heldin CH; Landström M Sci Signal; 2017 Jul; 10(486):. PubMed ID: 28676490 [TBL] [Abstract][Full Text] [Related]
2. The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner. Sorrentino A; Thakur N; Grimsby S; Marcusson A; von Bulow V; Schuster N; Zhang S; Heldin CH; Landström M Nat Cell Biol; 2008 Oct; 10(10):1199-207. PubMed ID: 18758450 [TBL] [Abstract][Full Text] [Related]
3. TRAF6 stimulates the tumor-promoting effects of TGFβ type I receptor through polyubiquitination and activation of presenilin 1. Gudey SK; Sundar R; Mu Y; Wallenius A; Zang G; Bergh A; Heldin CH; Landström M Sci Signal; 2014 Jan; 7(307):ra2. PubMed ID: 24399296 [TBL] [Abstract][Full Text] [Related]
4. USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor. Zhang L; Zhou F; Drabsch Y; Gao R; Snaar-Jagalska BE; Mickanin C; Huang H; Sheppard KA; Porter JA; Lu CX; ten Dijke P Nat Cell Biol; 2012 Jun; 14(7):717-26. PubMed ID: 22706160 [TBL] [Abstract][Full Text] [Related]
5. APPL proteins promote TGFβ-induced nuclear transport of the TGFβ type I receptor intracellular domain. Song J; Mu Y; Li C; Bergh A; Miaczynska M; Heldin CH; Landström M Oncotarget; 2016 Jan; 7(1):279-92. PubMed ID: 26583432 [TBL] [Abstract][Full Text] [Related]
6. RanBPM interacts with TβRI, TRAF6 and curbs TGF induced nuclear accumulation of TβRI. Zhang J; Ma W; Tian S; Fan Z; Ma X; Yang X; Zhao Q; Tan K; Chen H; Chen D; Huang BR Cell Signal; 2014 Jan; 26(1):162-72. PubMed ID: 24103590 [TBL] [Abstract][Full Text] [Related]
7. TGF-β-induced phosphorylation of Akt and Foxo transcription factors negatively regulates induced regulatory T cell differentiation. Kurebayashi Y; Baba Y; Minowa A; Nadya NA; Azuma M; Yoshimura A; Koyasu S; Nagai S Biochem Biophys Res Commun; 2016 Nov; 480(1):114-119. PubMed ID: 27697523 [TBL] [Abstract][Full Text] [Related]
8. TRAF6 interacts with and ubiquitinates PIK3CA to enhance PI3K activation. Wang Z; Liu Y; Huang S; Fang M FEBS Lett; 2018 Jun; 592(11):1882-1892. PubMed ID: 29729098 [TBL] [Abstract][Full Text] [Related]
9. TbetaRI independently activates Smad- and CD2AP-dependent pathways in podocytes. Xavier S; Niranjan T; Krick S; Zhang T; Ju W; Shaw AS; Schiffer M; Böttinger EP J Am Soc Nephrol; 2009 Oct; 20(10):2127-37. PubMed ID: 19679673 [TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor β induces bone marrow mesenchymal stem cell migration via noncanonical signals and N-cadherin. Dubon MJ; Yu J; Choi S; Park KS J Cell Physiol; 2018 Jan; 233(1):201-213. PubMed ID: 28213973 [TBL] [Abstract][Full Text] [Related]
11. TRAF6 promotes TGFβ-induced invasion and cell-cycle regulation via Lys63-linked polyubiquitination of Lys178 in TGFβ type I receptor. Sundar R; Gudey SK; Heldin CH; Landström M Cell Cycle; 2015; 14(4):554-65. PubMed ID: 25622187 [TBL] [Abstract][Full Text] [Related]
12. TGF-β1/ALK5-induced monocyte migration involves PI3K and p38 pathways and is not negatively affected by diabetes mellitus. Olieslagers S; Pardali E; Tchaikovski V; ten Dijke P; Waltenberger J Cardiovasc Res; 2011 Aug; 91(3):510-8. PubMed ID: 21478266 [TBL] [Abstract][Full Text] [Related]
13. Activation of PI3K/Akt signaling by n-terminal SH2 domain mutants of the p85α regulatory subunit of PI3K is enhanced by deletion of its c-terminal SH2 domain. Hofmann BT; Jücker M Cell Signal; 2012 Oct; 24(10):1950-4. PubMed ID: 22735814 [TBL] [Abstract][Full Text] [Related]
14. TRAF4 promotes TGF-β receptor signaling and drives breast cancer metastasis. Zhang L; Zhou F; García de Vinuesa A; de Kruijf EM; Mesker WE; Hui L; Drabsch Y; Li Y; Bauer A; Rousseau A; Sheppard KA; Mickanin C; Kuppen PJ; Lu CX; Ten Dijke P Mol Cell; 2013 Sep; 51(5):559-72. PubMed ID: 23973329 [TBL] [Abstract][Full Text] [Related]
15. Novel roles of Akt and mTOR in suppressing TGF-beta/ALK5-mediated Smad3 activation. Song K; Wang H; Krebs TL; Danielpour D EMBO J; 2006 Jan; 25(1):58-69. PubMed ID: 16362038 [TBL] [Abstract][Full Text] [Related]
16. Progressive tumor formation in mice with conditional deletion of TGF-beta signaling in head and neck epithelia is associated with activation of the PI3K/Akt pathway. Bian Y; Terse A; Du J; Hall B; Molinolo A; Zhang P; Chen W; Flanders KC; Gutkind JS; Wakefield LM; Kulkarni AB Cancer Res; 2009 Jul; 69(14):5918-26. PubMed ID: 19584284 [TBL] [Abstract][Full Text] [Related]
17. TGF-β effects on prostate cancer cell migration and invasion are mediated by PGE2 through activation of PI3K/AKT/mTOR pathway. Vo BT; Morton D; Komaragiri S; Millena AC; Leath C; Khan SA Endocrinology; 2013 May; 154(5):1768-79. PubMed ID: 23515290 [TBL] [Abstract][Full Text] [Related]
18. TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta. Yamashita M; Fatyol K; Jin C; Wang X; Liu Z; Zhang YE Mol Cell; 2008 Sep; 31(6):918-24. PubMed ID: 18922473 [TBL] [Abstract][Full Text] [Related]
19. TGF-β1 induces tissue factor expression in human lung fibroblasts in a PI3K/JNK/Akt-dependent and AP-1-dependent manner. Wygrecka M; Zakrzewicz D; Taborski B; Didiasova M; Kwapiszewska G; Preissner KT; Markart P Am J Respir Cell Mol Biol; 2012 Nov; 47(5):614-27. PubMed ID: 22771387 [TBL] [Abstract][Full Text] [Related]